EMAIL THIS PAGE TO A FRIEND

Lancet (London, England)

Rescue of haemopoiesis by a combination of growth factors including stem-cell factor.


PMID 11073025

Abstract

We observed an unexpectedly rapid rise in platelet counts with complete haematological recovery after a BEAM regimen, in a patient who could not be rescued by autologous transplant but who received filgrastim, epoetin alfa, and ancestim. We feel that these results may be attributed to this specific growth factor combination, including ancestim, a cytokine known to act on primitive stem cells. If confirmed, this observation may open new possibilities in intensive chemotherapy for patients for whom haematopoietic progenitors are difficult to harvest. This may also represent an alternative to ex-vivo expansion and deserves further investigation.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

Y0000251 Molgramostim, European Pharmacopoeia (EP) Reference Standard